As Abbvie (ABBV) Shares Rose, Sabal Trust Co Has Lowered Stake; Murphy Usa (MUSA) Holder Cutter & Company Brokerage Decreased Its Stake by $510,952 as Stock Rose

February 20, 2018 - By Marguerite Chambers

Cutter & Company Brokerage Inc decreased its stake in Murphy Usa Inc (MUSA) by 9.2% based on its latest 2017Q3 regulatory filing with the SEC. Cutter & Company Brokerage Inc sold 7,514 shares as the company’s stock rose 5.31% with the market. The institutional investor held 74,177 shares of the automotive aftermarket company at the end of 2017Q3, valued at $5.12 million, down from 81,691 at the end of the previous reported quarter. Cutter & Company Brokerage Inc who had been investing in Murphy Usa Inc for a number of months, seems to be less bullish one the $2.57B market cap company. The stock decreased 0.12% or $0.09 during the last trading session, reaching $75.23. About 30,515 shares traded. Murphy USA Inc. (NYSE:MUSA) has risen 4.83% since February 20, 2017 and is uptrending. It has underperformed by 11.87% the S&P500.

Sabal Trust Co decreased its stake in Abbvie Inc (ABBV) by 9.95% based on its latest 2017Q3 regulatory filing with the SEC. Sabal Trust Co sold 38,151 shares as the company’s stock rose 6.17% with the market. The institutional investor held 345,442 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $30.70 million, down from 383,593 at the end of the previous reported quarter. Sabal Trust Co who had been investing in Abbvie Inc for a number of months, seems to be less bullish one the $191.75B market cap company. The stock increased 1.81% or $2.15 during the last trading session, reaching $120.75. About 3.39 million shares traded. AbbVie Inc. (NYSE:ABBV) has risen 10.63% since February 20, 2017 and is uptrending. It has underperformed by 6.07% the S&P500.

Among 7 analysts covering Murphy USA (NYSE:MUSA), 1 have Buy rating, 2 Sell and 4 Hold. Therefore 14% are positive. Murphy USA had 18 analyst reports since September 8, 2015 according to SRatingsIntel. The firm has “Overweight” rating given on Tuesday, September 8 by JP Morgan. Jefferies maintained Murphy USA Inc. (NYSE:MUSA) on Monday, July 17 with “Buy” rating. Jefferies maintained it with “Buy” rating and $86.0 target in Tuesday, September 5 report. The firm earned “Hold” rating on Friday, February 2 by Stephens. The stock of Murphy USA Inc. (NYSE:MUSA) earned “Buy” rating by Jefferies on Thursday, June 9. Jefferies maintained Murphy USA Inc. (NYSE:MUSA) on Friday, August 4 with “Buy” rating. The stock has “Underweight” rating by JP Morgan on Tuesday, November 7. On Wednesday, April 19 the stock rating was downgraded by Wells Fargo to “Market Perform”. The firm earned “Buy” rating on Wednesday, July 27 by Jefferies. On Thursday, January 4 the stock rating was maintained by Wells Fargo with “Hold”.

Investors sentiment decreased to 0.72 in 2017 Q3. Its down 0.06, from 0.78 in 2017Q2. It is negative, as 28 investors sold MUSA shares while 88 reduced holdings. 26 funds opened positions while 57 raised stakes. 32.81 million shares or 5.74% less from 34.81 million shares in 2017Q2 were reported. Glenmede Trust Company Na reported 798 shares or 0% of all its holdings. Loring Wolcott And Coolidge Fiduciary Advisors Ltd Liability Partnership Ma accumulated 0% or 10 shares. First Manhattan accumulated 0% or 2,010 shares. 16,641 were reported by Mason Street Advsrs. Qs Invsts Limited Liability Co accumulated 5 shares. Tower Rech Cap Limited Liability Corporation (Trc) holds 206 shares or 0% of its portfolio. Bb&T Corp stated it has 0.14% in Murphy USA Inc. (NYSE:MUSA). City reported 72 shares. Principal stated it has 375,477 shares or 0.03% of all its holdings. Goldman Sachs Gp holds 0.01% of its portfolio in Murphy USA Inc. (NYSE:MUSA) for 706,476 shares. 2,100 are held by Old Mutual Customised Solutions (Proprietary) Limited. Oregon Public Employees Retirement Fund reported 0.01% of its portfolio in Murphy USA Inc. (NYSE:MUSA). 132,300 are held by Spark Ltd Llc. Gamco Invsts Et Al invested 0.15% in Murphy USA Inc. (NYSE:MUSA). Peak6 Invs Limited Partnership holds 0% or 4,214 shares in its portfolio.

Among 21 analysts covering Abbvie Inc (NYSE:ABBV), 10 have Buy rating, 2 Sell and 9 Hold. Therefore 48% are positive. Abbvie Inc had 78 analyst reports since July 21, 2015 according to SRatingsIntel. The stock has “Hold” rating by Cowen & Co on Friday, July 28. The firm has “Buy” rating by TheStreet given on Tuesday, August 11. The rating was maintained by Barclays Capital with “Equal-Weight” on Friday, October 13. UBS maintained AbbVie Inc. (NYSE:ABBV) rating on Friday, October 23. UBS has “Buy” rating and $78 target. Jefferies maintained the stock with “Buy” rating in Tuesday, January 16 report. The rating was maintained by Goldman Sachs on Friday, March 10 with “Buy”. On Sunday, October 29 the stock rating was maintained by SunTrust with “Buy”. The company was upgraded on Wednesday, October 11 by Cowen & Co. Jefferies maintained AbbVie Inc. (NYSE:ABBV) on Thursday, May 25 with “Buy” rating. The rating was maintained by Jefferies with “Buy” on Thursday, January 4.

Since September 11, 2017, it had 0 buys, and 5 selling transactions for $25.59 million activity. Schumacher Laura J also sold $14.07 million worth of AbbVie Inc. (NYSE:ABBV) shares. The insider SALEKI-GERHARDT AZITA sold 8,300 shares worth $705,655. Gosebruch Henry O had sold 18,300 shares worth $1.66M. Shares for $8.57M were sold by RICHMOND TIMOTHY J..

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>